Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(881/week)
Manufacturing
(428/week)
Technology
(895/week)
Energy
(315/week)
Software
(266/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Autosomal dominant polycystic kidney disease
Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
Apr 30, 2020
US Societal Economic Burden of an Inherited Kidney Disease Estimated at $7-10 Billion
Mar 12, 2020
Regulus Reports Fourth Quarter and Year-End 2019 Financial Results and Recent Updates
Oct 16, 2019
Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting
Oct 15, 2019
Study Demonstrates Continuing Education Improved Health Care Providers' Knowledge of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Sep 12, 2019
Regulus Therapeutics Announces Publication in Nature Communications Identifying RGLS4326 as a Potential Promising Treatment for ADPKD
Aug 08, 2019
Regulus Therapeutics Reports Second Quarter 2019 Financial Results and Recent Updates
Jul 23, 2019
Regulus Therapeutics Announces RGLS4326 Program Update
May 09, 2019
Regulus Therapeutics Reports First Quarter 2019 Financial Results and Recent Updates
May 07, 2019
Regulus Therapeutics Announces Closing of First Tranche of $41.8 Million Private Placement of Equity
May 06, 2019
Regulus Therapeutics Announces Restructuring of Term Loan
Mar 15, 2019
Regulus Announces Transition of Research Leadership
Jan 31, 2019
2018 Pipeline Review on Renal Diseases - Which Companies are the Most Active within Each Pipeline
Jan 08, 2019
Slone Partners, Where People Are Our Science®, Places Frank Czerwiec M.D., Ph.D. as Chief Medical Officer at Goldfinch Bio
Nov 08, 2018
Regulus Reports Third Quarter 2018 Financial Results and Recent Updates
Oct 26, 2018
Research in Polycystic Kidney Disease Takes an Important Step Forward
Oct 22, 2018
Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018
Sep 26, 2018
Regulus Provides Pipeline Updates
May 10, 2018
PANTHERx® Specialty Pharmacy Selected by Otsuka to Distribute JYNARQUE
Page 1
››
Latest News
May 30, 2025
Laser Photonics Received NASDAQ Notice of Delisting for Failure to Satisfy a Continued Listing Rule or...
May 30, 2025
ATS to Participate in the Stifel 2025 Cross Sector Insight Conference
May 30, 2025
NuScale Power’s Small Modular Reactor (SMR) Achieves Standard Design Approval from U.S. Nuclear Regulatory...
May 30, 2025
Fiberon composite decking earns Green GOOD DESIGN® Award
May 30, 2025
Therma-Tru Doors earns Green GOOD DESIGN® Award for its energy-efficient options for every home
May 30, 2025
Lugee Li to Head Liquidmetal Asia Holdings
May 30, 2025
Kaiser Aluminum Corporation Publishes 2024 Sustainability Report
May 30, 2025
Enpro Inc. Completes Offering of $450 Million 6.125% Senior Notes Due 2033
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Seabed Security (30 September - 01 October 2025 in...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events